Prescriber Resources

Enrolling in THALOMID REMS

In order to prescribe THALOMID® (thalidomide), you must enroll in the THALOMID REMS program and agree to follow the requirements of the program. You can enroll by visiting BMS REMS Patient Safety, a website that allows prescribers to handle the REMS process for THALOMID REMS. You can also download the Prescriber Enrollment Form below and fax it to the REMS Call Center at 1-888-432-9325.

Prescriber Enrollment Form

Prescribing THALOMID for your patients

In order to receive THALOMID, your patients must also be enrolled in the THALOMID REMS program. You can enroll your patients and fill out a prescription form using BMS REMS Patient Safety. You and your patients can also complete your mandatory confidential surveys there.

Enroll Your Patients at 
BMS REMS Patient Safety
Patient Prescription Form

Remind your patients to download the REMS Companion App on their smartphones

The REMS Companion App lets your patients complete their mandatory surveys on their smartphone.

They can also get reminders when it’s time to complete the surveys by allowing notifications in the app.

Learning more about THALOMID REMS

For additional information about the THALOMID REMS program, please see the educational materials below.

Prescriber Guide to 
THALOMID REMS Program
THALOMID REMS 
At-A-Glance
Prescribing Information

Please report adverse drug experiences that are suspected to be associated with the use of THALOMID and any suspected pregnancy occurring during the treatment with THALOMID to THALOMID REMS using any of the following methods:

REPORTING TO THALOMID REMS
Toll-free:
1-800-721-5072 (Worldwide Patient Safety) or
1-888-423-5436 (REMS Call Center)
Fax:
1-908-673-9115
REPORTING TO THE FDA

Adverse drug experiences that are suspected to be associated with the use of THALOMID and any suspected pregnancy occurring during the treatment with THALOMID may also be reported to the FDA MedWatch Reporting System using any of the following methods:

Telephone:
1-800-FDA-1088
Fax:
1-800-FDA-0178
Mail to:
MedWatch
5600 Fishers Lane
Rockville, MD 20852-9787

For additional information about the THALOMID REMS program, please contact the REMS Call Center at 1-888-423-5436

THALOMID and THALOMID REMS are registered trademarks of Celgene Corporation, a Bristol-Myers Squibb Company.